2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Lymphoma Research
Lymphoma research stands at the forefront of cancer investigation, delving deep into understanding the complexities of this heterogeneous disease. Scientists explore various facets, from elucidating the genetic underpinnings to deciphering the immune responses involved. Novel therapies such as immunotherapy and targeted treatments emerge from this research, offering hope to patients with lymphomas resistant to conventional approaches. Clinical trials, a cornerstone of lymphoma research, pave the way for breakthroughs, evaluating new drugs and treatment combinations. Furthermore, researchers delve into personalized medicine, tailoring treatments based on individual genetic profiles to enhance efficacy and minimize side effects. Collaborative efforts across disciplines drive progress, with the ultimate goal of improving outcomes and quality of life for those affected by lymphoma.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China